美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPDR S&P Biotech ETF

151.40

-2.3700-1.54%

盘后：151.630.2300+0.15%17:51 EDT

成交量：604.49万

成交额：9.19亿

市值：101.10亿

市盈率：8.30

高：154.12

开：153.43

低：151.10

收：153.77

52周最高：169.89

52周最低：103.43

股本：6,677.50万

流通股本：6,677.50万

量比：0.51

换手率：9.05%

股息：0.54

股息率：0.36%

每股收益(TTM):18.23

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

医疗保健行业综述：市场观察

生物医药板块全线走低诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖

北京亦庄综合保税区通过验收一周年进出口额突破140亿元

中国新闻网

医疗板块市场综述：行业快讯集锦

医疗保健板块市场动态综述

生物医药板块强势劲方医药-B（02595）涨8.01% 机构指医药工业“十五五”规划有标志性意义

“木头姐”斥资约3427万美元大笔增持Meta，加码医疗与生物科技

医疗保健板块市场快讯汇总

医疗保健板块市场快讯综述

“4连板”牛股发声！

每日经济新闻

立足张江链接全球——上海医药以“生态链主”担当共筑生物医药开源创新生态

医药经济报

万孚生物在上海成立生物科技公司

医疗保健板块市场综述：市场快讯

医疗保健板块快讯：市场动态一览

太空生物医药加速产业化，中科宇航与广州国家实验室携手“上天”

健康险“提质”周年考：产品上新与监管纠偏并行，支付端再添推力

德国央行：由于能源和医疗保健因素，德国通胀将保持高位。

尾盘异动！港股全线上涨，生物医药大爆发

医疗保健板块动态：市场快讯综述

大摩：对中国医疗健康行业维持吸引的行业观点

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/XBI/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":151.4,"timestamp":1791835200000,"preClose":153.77,"halted":0,"volume":6044907,"hourTrading":{"tag":"盘后","latestPrice":151.63,"preClose":151.4,"latestTime":"17:51 EDT","volume":3621,"amount":547537.2036,"timestamp":1791841889822,"change":0.23,"changeRate":0.001519,"amplitude":0.008388},"delay":0,"changeRate":-0.015412629251479511,"floatShares":66775000,"shares":66775000,"eps":18.23,"marketStatus":"盘后交易","change":-2.37,"latestTime":"10-12 18:08:18 EDT","open":153.43,"high":154.12,"low":151.1,"amount":919302565.36602,"amplitude":0.01964,"askPrice":151.69,"askSize":200,"bidPrice":151.25,"bidSize":700,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":153.77,"sharesOutstanding":63325000,"nav":153.722719,"aum":10430086474.925,"dividendRate":0.003555,"bidAskSpread":0.000294,"preHourTrading":{"tag":"盘前","latestPrice":153.9,"preClose":153.77,"latestTime":"09:26 EDT","volume":6687,"amount":1030664.76894,"timestamp":1791811594916,"change":0.13,"changeRate":0.000845,"amplitude":0.00676},"postHourTrading":{"tag":"盘后","latestPrice":151.63,"preClose":151.4,"latestTime":"17:51 EDT","volume":3621,"amount":547537.2036,"timestamp":1791841889822,"change":0.23,"changeRate":0.001519,"amplitude":0.008388},"volumeRatio":0.513925,"impliedVol":0.3238,"impliedVolPercentile":0.6574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66775000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.513925,"shares":66775000,"dividePrice":0.5382,"high":154.12,"amplitude":0.01964,"preClose":153.77,"low":151.1,"week52Low":103.43,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":151.4,"committee":0.555556,"eps":18.23,"divideRate":0.003555,"volume":6044907,"delay":0,"ttmEps":18.23,"open":153.43,"prevYearClose":121.93,"prevWeekClose":153.77,"prevMonthClose":157.68,"prevQuarterClose":157.68,"fiveDayClose":156.19,"twentyDayClose":157.6,"sixtyDayClose":154.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166923246","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1166923246","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166923246?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 16:29","pubTimestamp":1790238549,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察。0721 GMT——Hikma Pharmaceuticals新任首席财务官是“高水准人选”，RBC Capital Markets的Harry Sephton表示。这家伦敦上市的制药公司周四任命ViiV Healthcare的Rebecca Hall为下一任首席财务官。RBC称，Hall在ViiV和GSK积累的运营及财务经验应能很好地迁移至Hikma。该分析师预计Hikma将实现有序过渡，临时首席财务官Areb Kurdi将留任至Hall明年上任。由于公立医院入住率居高不下，患者转向私立医院，IHH的业务预计将从中受益。CIMB维持对马来西亚医疗保健板块的增持评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","BK4588","LABU","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451177","title":"生物医药板块全线走低 诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451177","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451177?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 13:36","pubTimestamp":1790228201,"startTime":"0","endTime":"0","summary":"金吾财讯 |  港股生物医药板块午后全线走低，截至发稿，诺诚健华 跌10.48%，荣昌生物跌7.99%，复宏汉霖跌7.68%，康诺亚-B跌5.86%，再鼎医药跌5.32%，君实生物跌4.53%，金斯瑞生物科技跌4.21%，康方生物跌3.54%，科伦博泰生物跌3.11%，泰格医药跌2.35%，药明生物跌1.80%，百济神州跌1.56%，药明合联跌1.12%。消息面上，国盛证券发布研报称，医药行业需求尚未明显回暖，降本增效、费用精细化管理已成为利润端的重要支撑。下半年关注流感旺季带来的阶段性需求催化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","BK1583","XBI","09926","LU0516422366.SGD","LU1303224171.USD","SG9999002463.SGD","LU0828237510.HKD","09688","02268","01877","SG9999014674.SGD","LU2039709279.SGD","06160","LU0456846285.SGD","BK1141","BK1515","LU1242518931.SGD","LU1961090484.USD","399441","02162","LU1880383366.USD","LU1719994722.HKD","688428","LU0348783233.USD","LU0540923850.HKD","LU0856984785.SGD","06990","BK4581","LU0140636845.USD","09969","BK1576","LU1770034418.SGD","02696","LU3063872942.SGD","SG9999002562.SGD","LU2328871848.SGD","02269","03347","09995","LU2399975544.HKD","LU0561508036.HKD","01548","LU0516423174.USD","161726","KURE","LU0348825331.USD","LU0348766576.USD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669145507","title":"北京亦庄综合保税区通过验收一周年 进出口额突破140亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669145507","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669145507?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 11:32","pubTimestamp":1790220720,"startTime":"0","endTime":"0","summary":"中新网北京9月24日电 北京亦庄综合保税区进出口额突破140亿元，规模位居北京四大综保区第二位，跻身全国综保区中上游梯队。北京亦庄近日联合北京海关签署《关于促进北京亦庄综合保税区高质量发展合作机制》，明确九大重点发展任务，建立常态化关地联席会议协同机制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-09-24/doc-iniswvxm0597356.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-24/doc-iniswvxm0597356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177158344","title":"医疗板块市场综述：行业快讯集锦","url":"https://stock-news.laohu8.com/highlight/detail?id=1177158344","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177158344?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 00:22","pubTimestamp":1790180558,"startTime":"0","endTime":"0","summary":"最新一期的医疗板块市场快讯已发布，涵盖多项关键动态，仅在道琼斯通讯社于美东时间4:20、12:20及16:50独家呈现。罗氏股价上涨0.8%。下午10:46——肯纳格投资银行分析师Raymond Choo Ping Khoon在一份报告中指出，IHH医疗保健年初至今股价累计下跌10%，这可能为投资者提供了一个潜在的入场时机，因为该公司在关键市场的业务运营预计将有所改善。在印度，Gleneagles医疗的利润率有望向Fortis Healthcare看齐；同时，若大中华区业务亏损收窄速度快于预期，或能带来更多上行空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163794674","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1163794674","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163794674?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 16:24","pubTimestamp":1790151852,"startTime":"0","endTime":"0","summary":"涵盖医疗保健领域的市场快讯，仅通过道琼斯通讯社于美东时间4:20、12:20和16:50独家发布。0246 GMT——肯纳格投行分析师Raymond Choo Ping Khoon指出，IHH医疗保健股价年初至今已回落10%，这或许正为投资者敞开一扇潜在的低吸窗口，预期其在关键市场的运营表现将逐步改善。0909 GMT——贝伦贝格分析师认为，诺和诺德在投资者日过后股价8%的跌幅实属过度反应，但这也恰恰印证了市场对2027年的担忧情绪犹存——既担心预期中的价格压力，又对CagriSema药物的上市前景持怀疑态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4585","BK4581","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171299","title":"生物医药板块强势 劲方医药-B（02595）涨8.01% 机构指医药工业“十五五”规划有标志性意义","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171299","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171299?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 10:49","pubTimestamp":1790131753,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块强势，恒生生物科技、恒生医疗保健指数涨幅均超1%。消息面上，9月18日，工信部、国家发改委等十部门发布医药工业“十五五”规划，对首创新药、创新医疗器械、产业链自主可控与国际化等提出要求，积极鼓励创新药及其产业链，制药装备，精准诊疗产业链。","market":"us","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992289","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1141","09939","BK1515","HK0000320264.USD","161726","HK0000320223.HKD","HK0000306685.HKD","399441","BK1191","01548","XBI","07666","06127","02126","BK4581","BK1583","BK1161","BK4585","HK0000306701.USD","09966","BK4588","06185","02410","BK1574","BK1576","02617","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669176755","title":"“木头姐”斥资约3427万美元大笔增持Meta，加码医疗与生物科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2669176755","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669176755?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 09:43","pubTimestamp":1790127838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GDOC","XBI","GBTC","BFAP","CBOJ","ARKQ","ARKX","BFJL","BTRN","MEDX","XBTY","BAGY","YBTC","IEIH","BITY","BTCL","IBBJ","MNRS","AGNG","BTC","SYNB","HODL","SBIT","DEFI","CBXO","DFII","LNGR","BITI","ARKG","CBTY","BTCC","MAXI","BETE","ARKW","EZBC","BCCC","CBTJ","ARKK","BITU","BTF","BITB","ARKB","QBF","CBTA","FBTC","BITX","CBXY","SARK","CBOA","ARKF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150507917","title":"医疗保健板块市场快讯汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=1150507917","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150507917?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 04:53","pubTimestamp":1790110396,"startTime":"0","endTime":"0","summary":"美东时间0638——诺和诺德在资本市场日活动上公布的多元化战略及模糊的中期销售目标，令投资者颇感失望，AlphaValue分析师Abhishek Raval如此写道。\"面对对单一分子的过度依赖，激进而大规模的业务多元化押注，加上无可挑剔的商业执行力，已是当务之急。\"然而，市场对此心存疑虑，Raval表示。AlphaValue对该丹麦药企股票给予买入评级，目标价450丹麦克朗。股价微跌0.2%，报259.40克朗。这家法意合资的眼镜集团近期因市场担心该领域将涌入新竞争者而承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113321759","title":"医疗保健板块市场快讯综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1113321759","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113321759?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 00:23","pubTimestamp":1790094199,"startTime":"0","endTime":"0","summary":"0638 GMT - 诺和诺德的资本市场日活动公布了一系列消息，其中包括业务多元化计划及一个略显模糊的中期销售目标。然而，AlphaValue分析师阿布希谢克·拉瓦尔指出，这些内容并未令投资者感到满意。不过，市场对此仍心存疑虑。AlphaValue给予这家丹麦制药商的股票“买入”评级，目标价为450丹麦克朗。该股现跌0.2%，报259.40克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","BK4585","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144824","title":"“4连板”牛股发声！","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144824","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144824?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 20:11","pubTimestamp":1790079060,"startTime":"0","endTime":"0","summary":"公司细胞治疗相关技术与产品尚处于研发阶段，无创新药上市或进入到临床试验阶段；节能环保板块主要从事碳酸锂业务、废钢再生资源及配套加工销售等业务。根据南华生物8月23日发布的《2026年半年度报告》，公司主营业务为生物医药和节能环保两大板块。股价方面，今年以来南华生物股价整体呈上涨态势，数据显示，其股价年初至今累计涨幅约35.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-09-22/doc-inistewx8880407.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-22/doc-inistewx8880407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","XBI","BK4523","BK4585","TTM","BK4581","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141693","title":"立足张江 链接全球——上海医药以“生态链主”担当共筑生物医药开源创新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141693","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141693?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 18:41","pubTimestamp":1790073660,"startTime":"0","endTime":"0","summary":"9月17日，2026张江药谷大会暨上海国际生物医药产业周在张江科学会堂开幕。置身全球生物医药创新浪潮，上海医药正以“链主”担当，发挥工商研投一体化全产业链优势，联结政产学研资各方力量，推动开放共享的开源创新生态加速成形。立足上海、辐射全国、链接全球，上海医药正与业界各方合力共绘中国生物医药产业全球化新蓝图。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-22/doc-inistewx8860205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0099","BK4581","BK0188","161726","BK0187","399441","BK4588","BK0196","02607","BK0183","BK0209","601607","BK1197","XBI","BK0184","BK0028","BK4585","BK0097","BK0012","BK0020","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669118768","title":"万孚生物在上海成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2669118768","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669118768?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 12:08","pubTimestamp":1790050099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","SYNB","BK4588","BK4585","BK4581","MEDX","LNGR","XBI","IBBJ","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184742504","title":"医疗保健板块市场综述：市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1184742504","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184742504?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 04:53","pubTimestamp":1790024004,"startTime":"0","endTime":"0","summary":"0655 GMT - 瑞银分析师在一份报告中指出，Lundbeck针对癫痫候选药物bexicaserin的研究结果，或有望迅速证明这家丹麦药企多年致力于扭转其研发业务的努力正在初见成效。分析师们表示，研究结果可能凸显该药物成为重磅产品的潜力，并成为Lundbeck从精神病学传统领域转向试验结果更可预测领域战略转变的首个数据点。\"瑞银将Lundbeck股票评级从中性上调至买入，目标价从45丹麦克朗提升至52丹麦克朗。该公司股价上涨2.9%，报43.80丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4585","LABU","ITM","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127208050","title":"医疗保健板块快讯：市场动态一览","url":"https://stock-news.laohu8.com/highlight/detail?id=1127208050","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127208050?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 00:22","pubTimestamp":1790007770,"startTime":"0","endTime":"0","summary":"0655 GMT——瑞银分析师在报告中指出，丹麦制药商Lundbeck旗下癫痫候选药物bexicaserin的临床研究结果，或将很快印证该公司多年来致力于扭转研发业务的努力已初见成效。分析师们表示，这项研究数据有望凸显该药物成为重磅产品的潜力，同时也会成为Lundbeck从精神病学传统领域转向试验结果更可预测领域的一个关键转折点。基于此判断，瑞银将Lundbeck股票评级从中性上调至买入，目标价亦由45丹麦克朗提升至52丹麦克朗。受此提振，该公司股价上扬2.9%，报43.80丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","BK4585","ITM","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669164352","title":"太空生物医药加速产业化，中科宇航与广州国家实验室携手“上天”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669164352","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669164352?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 21:46","pubTimestamp":1789998360,"startTime":"0","endTime":"0","summary":"第一财经记者独家获悉，近期，中科宇航与广州国家实验室在太空生物医药领域达成合作，联合研制太空制药载荷。在广州国家实验室徐强研究组，第一财经记者见到了“全视场细胞成像仪”，该设备由中科宇航与广州国家实验室联合研制。如今，广州国家实验室与中科宇航成立了相应的工作小组，组内有来自中科宇航的总体工程师以及各分系统工程师，也有徐强团队的装备研制人员，还有来自广州国家实验室从事药物实验的科研人员。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-09-21/doc-inisqzyc2767301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","161726","BK4585","BK4581","399441","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166405","title":"健康险“提质”周年考：产品上新与监管纠偏并行，支付端再添推力","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166405","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166405?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 20:51","pubTimestamp":1789995060,"startTime":"0","endTime":"0","summary":"9月21日，北京商报记者梳理发现，一年过去，行业在产品服务创新与监管纠偏两条线上同步推进。除了产品在变，监管在收紧，政策推力也在加码。建议监管部门加快出台健康险产品创新发展的具体方案。2026年政府工作报告首次明确提出“加快发展商业健康保险”。2025年12月，首版《商业健康保险创新药品目录》正式发布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-21/doc-inisqzxv7582232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","XBI","BK4585","BK4588","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669715298","title":"德国央行：由于能源和医疗保健因素，德国通胀将保持高位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669715298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669715298?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 18:03","pubTimestamp":1789985000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","NOBL","BK4585","BK4581","BK4550","XLV","CGVV","FLGR","LABU","BK4588","FGM","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669356154","title":"尾盘异动！港股全线上涨，生物医药大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2669356154","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669356154?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 17:18","pubTimestamp":1789982280,"startTime":"0","endTime":"0","summary":"【导读】三大指数集体上涨，恒指重返25000点，生物医药板块大爆发9月21日，港股三大指数低开后震荡走高，午后升幅进一步扩大，最终集体收涨。截至发稿，恒生指数重返25000点之上，报25042.7 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680130705.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680130705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["399441","161726","XBI","BK4585","KCAI","BK4581","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196076014","title":"医疗保健板块动态：市场快讯综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1196076014","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196076014?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 16:25","pubTimestamp":1789979119,"startTime":"0","endTime":"0","summary":"0444 GMT - 海天国际在首席执行官增持公司股份后，呈现出颇具吸引力的入场点位，花旗分析师Eric Lau在一份报告中指出。该分析师表示，此次增持的时机也印证了公司下半年盈利复苏的预期。花旗预计，这家塑料注塑机制造商的国内销售将推动其下半年业绩，从而抵消海外销售的疲软态势。该投行预计下半年营收与净利润将分别同比增长2.3%和5.0%。花旗维持其买入评级，目标价定为27港元，理由是估值并不高昂。股价目前上涨3.6%，报17.69港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","ITM","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669588361","title":"大摩：对中国医疗健康行业维持吸引的行业观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2669588361","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669588361?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 14:25","pubTimestamp":1789971900,"startTime":"0","endTime":"0","summary":"9月21日消息，摩根士丹利(MS.US)发表研报指，《医药工业发展“十五五”规划》提到，目标中国创新药行业在2030年复合年增长逾20%，相当于行业规模扩大至现时约2.5倍。规划亦明确支持中国生物 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680119444.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680119444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0053666078.USD","LU0320765646.SGD","LU1989772923.USD","LU2028103732.USD","LU0528227936.USD","LU1668664300.SGD","LU2089283258.USD","IXJ","KBWB","LU0314104364.USD","LU1244550494.USD","BK4504","LU0098860793.USD","LU1732799900.SGD","LU0912757837.SGD","LU0225283273.USD","LU0267386448.USD","LU1791710582.SGD","LU2357305700.SGD","VHT","IAI","LABU","LU1363072403.SGD","BK4581","LU1162221912.USD","LU1244550577.SGD","XLV","LU0390134368.USD","LU1720051108.HKD","LU0971096721.USD","LU2089284900.SGD","LU1720051017.SGD","LU2264538146.SGD","BK4585","BK4588","LU1988902786.USD","LU0006306889.USD","IE00BKVL7J92.USD","BK4534","IE00B775SV38.USD","IE00BZ1G4Q59.USD","LU0882574139.USD","LU0210528500.USD","XBI","159760","LU0795875086.SGD","LU2133065610.SGD","IE00B3S45H60.SGD","LU0234570918.USD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}